Transtema: M&A Fueled Growth Ahead - Redeye

Redeye retains its positive view on Transtema following a Q1 report with underlying sales and EBITA in line with our forecasts. From Q2 and onwards, Tessta, which had a solid start to 2022, will be fully consolidated, driving sales and earnings.

Länk till analysen i sin helhet: https://www.redeye.se/research/841201/transtema-ma-fueled-growth-ahead?utm_source=finwire&utm_medium=RSS